Conversion therapy and suitable timing for subsequent salvage surgery for initially unresectable hepatocellular carcinoma: What is new?

Table 2 Studies on associating liver partition and portal vein ligation for staged hepatectomy and future liver remnant % changes between stage 1 and stage 2 over nearly 5 years

Ref.	Year	Cases	FLR%1	FLR%2	FLR%3	Morbidity	Mortality	Feasibility
[106]	2017	20	15	41 (24-67)	88	NM	0	100
[107]	2016	295	26	39	74	NM	7.5	NM
[108]	2016	17	24.2	38.5 (27.9-56.9)	-	11.8	5.9	100
[69]	2015	12	15	35 (26-53)	160	NM	0	100
[109]	2015	9	21.1	32.2 (26.5-37.9)	96	66.7	1	100
[110]	2015	62	24.2	39.1 (22.3-72.2)	48.6	80	12.9	95.2
[111]	2015	11	33.9	46.3 (36.2-55.8)	140	45	9.1	100
[70]	2014	15	22.6	36.3 (30-59.2)	87.2	66.7	28.7	100
[68]	2014	48	23	41 (34-47)	77.4	NM	17	100
[13]	2013	15	27	46.9 (31.7-67)	78.4	53	0	100
[112]	2013	9	22.9	NM	87.2	68	12	100
[66]	2012	10	27.8	NM	82	40	0	100

¹FLR% before stage 1;

²FLR% before stage 2;

³FLR% between stage 1 and stage 2. NM: Not mentioned; FLR: Future liver remnant.